Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach
<b>Background/Objectives:</b> Fructose-driven metabolic disorders, such as obesity, non-alcoholic fatty liver disease (NAFLD), dyslipidemia, and type 2 diabetes, are significant global health challenges. Ketohexokinase C (KHK-C), a key enzyme in fructose metabolism, is a promising therap...
Saved in:
Main Authors: | Tilal Elsaman, Magdi Awadalla Mohamed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/1/126 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics
by: Li Ting-Ting, et al.
Published: (2015-06-01) -
Kefir Prevents Adipose Tissue Growth Through the Induction of Apoptotic Elements in High-Fructose Corn Syrup-Fed Rats
by: Esra Aslan, et al.
Published: (2023-05-01) -
The Counteracting Effect of Chrysin on Dietary Fructose-Induced Metabolic-Associated Fatty Liver Disease (MAFLD) in Rats with a Focus on Glucose and Lipid Metabolism
by: Gabriela Campanher, et al.
Published: (2025-01-01) -
Fructose Consumption in Pregnancy and Associations with Maternal and Offspring Hepatic and Whole-Body Adiposity in Rodents: A Scoping Review
by: Grace Zhao, et al.
Published: (2025-01-01) -
Solid-State Modification Strategies for Alpha-Mangostin Solubility Enhancement: A Review on Recent Progress
by: Nurin Syamimi Ahmad Izuren Shah, et al.
Published: (2025-01-01)